secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001193125-22-206598
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals CLO Derek Meisner resigns effective Aug 22, 2022
-------------------------------------------------------------------

- Chief Legal Officer and Corporate Secretary Derek Meisner resigns effective August 22, 2022.
- Resignation is to pursue another opportunity; not due to any disagreement with the company or board.
- No replacement for Meisner has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000119312522206598/0001193125-22-206598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000119312522206598/d378391d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-206598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer